Between the ads, the headlines, and the friend who "just started it," it is hard to go a week without hearing about GLP-1 medications like semaglutide and tirzepatide. For women in perimenopause dealing with weight that will not budge despite doing everything that used to work, the appeal is obvious. But GLP-1 medications are a tool, not a complete plan, and understanding what they actually do, and do not do, matters before you start one.
Weight gain in perimenopause rarely comes from one cause. Declining estrogen can reduce insulin sensitivity, which makes it easier to store fat, particularly around the abdomen. Muscle mass tends to decline with age unless you are actively preserving it, and less muscle means a lower resting metabolic rate. Chronic stress and disrupted sleep, both common in this decade of life, raise cortisol, which further encourages abdominal fat storage and can drive cravings. This is why the exact eating and exercise pattern that worked in your 30s can stop working in your 40s and 50s, even with no change in effort.
GLP-1 receptor agonists, and dual GLP-1/GIP medications like tirzepatide, work primarily by increasing satiety signaling, slowing gastric emptying, and improving insulin sensitivity. In plain terms, they help you feel full sooner and stay full longer, which reduces overall intake, and they can meaningfully improve blood sugar regulation along the way. For many women, particularly those with clinically significant insulin resistance or obesity, this can be a real, evidence-supported piece of a weight and metabolic health plan.
"It's cheating." Using a medication that improves insulin sensitivity and satiety signaling is no more "cheating" than using a thyroid medication to correct low thyroid hormone. "It's only for people with diabetes." GLP-1 medications are FDA-approved for weight management in appropriate candidates independent of a diabetes diagnosis. "Once you start, you're on it forever." That is an individualized clinical decision, not a universal rule, and it depends heavily on what else is built alongside the medication.
The women who do best on a GLP-1 medication are usually the ones using it as one piece of a larger plan: a clinician who investigates why the weight gain started, adequate protein and strength training to protect muscle, labs monitored along the way for safety and progress, and a plan for what happens if or when the medication is eventually reduced or stopped by the prescribing clinician. That is the approach behind Weight and Metabolic Care at Root & Remedy Integrative Care: your GLP-1 is prescribed and managed by your own clinician, while we build the metabolic, nutrition, and muscle-preservation plan around it.
If you want to know whether this is the right starting point for you, take the free Healthspan Baseline quiz, or learn more about the Weight & Metabolic Care.
This article is for general education and is not medical advice. It does not diagnose or treat any condition, and it is not a recommendation for or against any specific medication. Please talk with your own healthcare provider about your individual situation.
Take the free Healthspan Baseline quiz, or book a Health Consultation to talk it through.
Take the free quiz